Effect of food on the bioavailability of amlodipine besylate/atorvastatin calcium combination tablet.
Chung
Menger
M
Pfizer Inc, New York, New York, USA.
Calcagni
Albert
A
Glue
Paul
P
Bramson
Candace
C
D000328:Adult; D017311:Amlodipine / Q000009:adverse effects / Q000493:pharmacokinetics*; D000924:Anticholesteremic Agents / Q000493:pharmacokinetics; D000959:Antihypertensive Agents / Q000009:adverse effects / Q000493:pharmacokinetics; D019540:Area Under Curve; D000069059:Atorvastatin; D001682:Biological Availability; D018592:Cross-Over Studies; D004041:Dietary Fats / Q000008:administration & dosage / Q000009:adverse effects / Q000493:pharmacokinetics; D006970:Disorders of Excessive Somnolence / Q000139:chemically induced; D004305:Dose-Response Relationship, Drug; D004338:Drug Combinations; D005260:Female; D018565:Food-Drug Interactions; D006207:Half-Life; D006261:Headache / Q000139:chemically induced; D006538:Heptanoic Acids / Q000009:adverse effects / Q000493:pharmacokinetics*; D006801:Humans; D008297:Male; D008875:Middle Aged; D011758:Pyrroles / Q000009:adverse effects / Q000493:pharmacokinetics*; D013607:Tablets; D013810:Therapeutic Equivalency
D000924:Anticholesteremic Agents; D000959:Antihypertensive Agents; D004041:Dietary Fats; D004338:Drug Combinations; D006538:Heptanoic Acids; D011758:Pyrroles; D013607:Tablets; D017311:Amlodipine; D000069059:Atorvastatin